CN108606134A - A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar - Google Patents
A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar Download PDFInfo
- Publication number
- CN108606134A CN108606134A CN201810287023.3A CN201810287023A CN108606134A CN 108606134 A CN108606134 A CN 108606134A CN 201810287023 A CN201810287023 A CN 201810287023A CN 108606134 A CN108606134 A CN 108606134A
- Authority
- CN
- China
- Prior art keywords
- parts
- inonotus obliquus
- sugar
- reducing pressure
- pressed candy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000414067 Inonotus obliquus Species 0.000 title claims abstract description 30
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 15
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 10
- 210000000003 hoof Anatomy 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 10
- 241000222684 Grifola Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- 241001619444 Wolfiporia cocos Species 0.000 claims abstract 3
- 230000000694 effects Effects 0.000 abstract description 12
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 7
- 230000009471 action Effects 0.000 abstract description 6
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract description 4
- 230000006837 decompression Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 description 7
- 244000197580 Poria cocos Species 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 206010017758 gastric cancer Diseases 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 201000011549 stomach cancer Diseases 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000747105 Fuscoporia Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 208000019065 cervical carcinoma Diseases 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 240000001080 Grifola frondosa Species 0.000 description 1
- 235000007710 Grifola frondosa Nutrition 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- -1 triterpene compound Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to field of health care food, i.e., a kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar.Its active ingredient is made of the raw material of following weight percent：25-35 parts of oligoisomaltose, 25-35 parts of Inonotus obliquus, wooden 10-15 parts of the hoof, 10-15 parts of grifola frondosus, 5-10 parts of Poria cocos.Prescription is prepared simply, at low cost.Formula has edibility, has no toxic side effect, safe and reliable.There is booster action to anticancer, decompression, hypoglycemic, cerebral thrombus can be prevented, body's immunity can be improved in long-term use.
Description
Technical field
The present invention relates to field of health care food, i.e., a kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar.
Background technology
In the prior art, in recent years, solid beverage industry steps into fast-developing channel, enterprise inside the circle's quantity and row
Industry production and marketing scale constantly expands.Solid beverage because of numerous in variety, unique flavor, using plant extracts as primary raw material, be easy to deposit
It puts and receives consumers, especially those have nutrition, health-care assistance effect rich in vitamin, minerals, Chinese medicine etc.
Nutrition needed for body metabolism can be replenished in time in the solid beverage of ingredient, more become the good companion being be unable to do without during many life are lived
Companion.National publication integration of drinking and medicinal herbs article, solid beverage can add Chinese medicine, for making health food, meet the people day
The tonic of beneficial demand, solid beverage have welcome development opportunity.
Invention content
The object of the present invention is to provide a kind of prescription is simple, there is nutrition and health care, it is anticancer adjuvant, decompression, hypoglycemic, antiviral
The Inonotus obliquus pressed candy of effect.
Technical solution of the invention：A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar, it is characterised in that
Its active ingredient is made of the raw material of following weight percent：25-35 parts of oligoisomaltose, 25-35 parts of Inonotus obliquus, wood
10-15 parts of hoof, 10-15 parts of grifola frondosus, 5-10 parts of Poria cocos.
It is preferred that or without being limited thereto：The Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar, by the original of following weight percent
Material is made：30 parts of oligoisomaltose, 30 parts of Inonotus obliquus, wooden 15 parts of the hoof, 15 parts of grifola frondosus, 10 parts of Poria cocos.
Preparation method：Through despecking, cleaning, extraction, drying and crushing, particle is made after be pressed into tablet.
The ingredient that main pharmacological is played in Inonotus obliquus is lanosterol type triterpenes, Inonotus obliquus alcohol, Inonotus obliquus
Element and lignin.With kinds of tumors such as resistance liver cancer, gastric cancer, lung cancer, cervical carcinoma, breast cancer, cutaneum carcinoma, the carcinoma of the rectum, lymphs
Cell and AIDS virus resisting, anti-infective, treatment diabetes, blood pressure lowering adjust blood fat, anti-body aging, strengthen immunity
Equal pharmacological actions.
The wooden hoof main component is the wooden hoof element, has the effect of disperse accumulation, stagnation resolvation, anticancer.Treat dyspepsia, the cancer of the esophagus, gastric cancer, son
The illnesss such as palace cancer.Pharmacological evaluation proves that the wooden hoof crude extract has the pharmacological actions such as antitumor, anti-oxidant, enhancing immune function.
Grifola frondosus has antitumor, hypoglycemic pharmacological action due to being rich in iron, copper and Vitamin C.It can prevent poor
Blood, scurvy, leucoderma prevent the generation of artery sclerosis and cerebral thrombus；Its selenium and chromium content is higher, there is protection liver, pancreas
It is dirty, prevent the effect of hepatic sclerosis and diabetes.Effect invigorating the spleen, QI invigorating, qi-restoratives.
Poria cocos main component is pachyman and pachymic acid, can preventing gastric ulcer, have preventive and therapeutic effect to hepatic injury；There is anticancer
Effect；And heart rate can be accelerated.Pharmacological evaluation shows that, with diuresis, antibacterial action, the immunocompetence of body can be improved.In addition, also
Having reduces blood glucose, reduces the effects that hydrochloric acid in gastric juice, enhancing isolated heart heart contracting.
Each ingredient synergistic effect can enhance antitumor action in prescription, and Inonotus obliquus, the wooden hoof, Poria cocos synergistic effect can
Enhance immunity of organisms, Inonotus obliquus, grifola frondosus, Poria cocos synergistic effect can enhance antitumor and hypoglycemic effect.
Dosage form of the present invention is without being limited thereto, may also be fabricated which that granule, powder, capsule or other field of health care food are routinely made
Agent.
Effect：Anticancer adjuvant, hypoglycemic, prevents cerebral thrombus at decompression.
Usage and dosage：It is recommended that per consumption per day 6-10 pieces.
Target user：The sub-health population of blood pressure, high blood glucose.
It is an advantage of the invention that：1. prescription is prepared simply, at low cost.2. formula have edibility, have no toxic side effect, safety, can
It leans on.3, decompression, hypoglycemic have booster action, can with anticancer, can prevent cerebral thrombus, body's immunity can be improved in long-term use.
4, it is taken through 60 blood pressures of cumulative statistics, high blood glucose crowd, effective percentage 100%.
Embodiments of the present invention are described in further detail below in conjunction with embodiment.
Specific implementation mode
Embodiment 1
A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar, is prepared from the following raw materials in parts by weight：Oligomeric different malt
30 parts of sugar, 30 parts of Inonotus obliquus, wooden 15 parts of the hoof, 15 parts of grifola frondosus, 10 parts of Poria cocos.
Test example
1. the experimental research achievements of pair Inonotus obliquus
Liver cancer, observation find Fuscoporia obliqua polysaccharide extract to liver cancer mouse HepA tumors inhibiting rate up to 39. 39 %,；Gastric cancer,
Inonotus obliquus extract has Inhibit proliferaton effect, inducing apoptosis of tumour cell to human gastric cancer BGC2823 cell strains, and shows
Go out dose-effect relationship；Lung cancer, influence of the observation Inonotus obliquus water decoction to patients with lung cancer intestinal flora, finds Inonotus obliquus group than single
Bifidobacteria is obviously more in the enteron aisle of pure chemotherapy group, and coccus quantity is few；Cervical carcinoma, the water extract of Inonotus obliquus can make one
The protein quantity and mitotic index of cervical cancer cell (HeLaS3) decline, and improve the cell number of mitosis metaphase,
The cell cycle is influenced, influences the metabolism of cell simultaneously to the mitosis of interference cell；Other tumours, golden light et al.
Observe that Fuscoporia obliqua polysaccharide has apparent inhibiting effect, the inhibition of large and small dosage group swollen the growth of small S180 sarcoma of rats
Ratio of outflow is respectively 56. 31 % and 44. 34 %
The triterpene compound and steroids of Inonotus obliquus have the work for improving blood circulation, adjusting blood pressure, reducing cholesterolemia
With clinical observation to Inonotus obliquus has certain effect to prevention and treatment hypertension, can reduce the blood pressure of hypertensive patient simultaneously
Mitigate symptom, has shared coordinative role with conventional buck medicine, kept blood pressure more easy to control and steady.
Inonotus obliquus, inonotus obliquus sclerotium and mycelial polysaccharide crude extract, have drop to alloxan diabetes mouse
Blood glucose acts on, and three's hypoglycemic effect is without significant difference.
2. the experimental research achievements of pair wooden hoof
The wooden hoof can dramatically the tolerance for improving experiment mice hypobaric hypoxia, extend its time-to-live, have antifatigue, high temperature resistance
Effect.And the flow velocity of anoxic body Mesentery microcirculation, fluidised form can be influenced, there is improvement result to microcirculation.
3. the experimental research achievements of pair Poria cocos
It can induce Turnover of Mouse Peritoneal Macrophages in su-fuling body and enter state of activation, antivirus action increases macrophage in vitro
By force, there is very strong inhibiting effect to humoral immunity and cellular immunity.
4. the experimental research achievements of pair grifola frondosus
Ohno etc. shows very strong antitumor activity from Grifola Frondosa sporophore with the Grifolan21N that hot water extracts,
After being injected intraperitoneally 5 times with the dosage of every 20 μ g of mouse, the inhibiting rate to mouse S180 solid tumors is 98%, completed tumor regression
Mouse be 7/10.The three kinds of Polysaccharides on Mice S180 solid tumors extracted from mycelium have apparent inhibiting effect.
It is described above, only specific implementation mode of the invention, various illustrations are not to the substantive content structure of the present invention
At limitation.
Claims (2)
1. a kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar, it is characterised in that its active ingredient is by following parts by weight
Raw material be made：25-35 parts of oligoisomaltose, 25-35 parts of Inonotus obliquus, wooden 10-15 parts of the hoof, 10-15 parts of grifola frondosus,
5-10 parts of Poria cocos.
2. the Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar described in accordance with the claim 1, it is characterised in that by following heavy
The raw material of amount number is made：30 parts of oligoisomaltose, 30 parts of Inonotus obliquus, wooden 15 parts of the hoof, 15 parts of grifola frondosus, 10 parts of Poria cocos.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810287023.3A CN108606134A (en) | 2018-03-30 | 2018-03-30 | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810287023.3A CN108606134A (en) | 2018-03-30 | 2018-03-30 | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108606134A true CN108606134A (en) | 2018-10-02 |
Family
ID=63659406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810287023.3A Pending CN108606134A (en) | 2018-03-30 | 2018-03-30 | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108606134A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106511442A (en) * | 2016-12-21 | 2017-03-22 | 河南爱因糖尿病健康科学研究院股份有限公司 | Inonotus obliquus compound tablet candy with function of reducing blood sugar and preparation method thereof |
| CN106727730A (en) * | 2016-12-31 | 2017-05-31 | 健务（上海）生物科技有限公司 | Adjust biological bacterium solution of immunity of organisms anticancer and preparation method thereof |
| CN106954855A (en) * | 2017-02-17 | 2017-07-18 | 江苏宇鸿生物科技有限责任公司 | A kind of anticancer composite fungi amylose and preparation method thereof |
-
2018
- 2018-03-30 CN CN201810287023.3A patent/CN108606134A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106511442A (en) * | 2016-12-21 | 2017-03-22 | 河南爱因糖尿病健康科学研究院股份有限公司 | Inonotus obliquus compound tablet candy with function of reducing blood sugar and preparation method thereof |
| CN106727730A (en) * | 2016-12-31 | 2017-05-31 | 健务（上海）生物科技有限公司 | Adjust biological bacterium solution of immunity of organisms anticancer and preparation method thereof |
| CN106954855A (en) * | 2017-02-17 | 2017-07-18 | 江苏宇鸿生物科技有限责任公司 | A kind of anticancer composite fungi amylose and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101160943B1 (en) | Health functional foods compositions for the prevention and amelioration of cancer containing the mixed extract of Phellinus linteus mycelium and cultured Panax Ginseng Cameyer as an active ingredient | |
| CN102687822B (en) | Wolfberry chewable tablet and manufacturing method thereof | |
| CN102600212B (en) | Medicinal health product for immunity enhancement and adjuvant treatment of tumor | |
| CN101589801B (en) | Process for manufacturing red ginseng honey slice | |
| Mittal et al. | A Critical Review on Ethnobotanical and Pharmacological Aspects of Euryale Ferox Salisb. | |
| KR20160006812A (en) | Compositions for preventing and curing diabetes comprising extract of Paeonia lactiflora | |
| KR20030055127A (en) | Composition for anti-hyperlipidemia | |
| CN105999096A (en) | Composition for enhancing immunity and application | |
| CN108576346A (en) | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar reducing blood lipid | |
| CN108606134A (en) | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar | |
| CN106798892B (en) | Chemotherapy combination anti-tumor traditional Chinese medicine composition with synergistic attenuation effect and application thereof | |
| KR20160135037A (en) | Compositions for preventing or treating metabolic disorders comprising an extract of Caragana Sinica | |
| KR20150031373A (en) | Phamaceutical and food composition for preventing or treating obesity comprising extract of leaf from Hoppophea rhamnoids as effective component | |
| KR20180049939A (en) | Medicinal composition for preventing or treating liver cancer and health functional food | |
| CN103110684A (en) | Soft capsule having assistant protective effect on gastric mucosa and preparation method thereof | |
| KR101514284B1 (en) | The pharmaceutical composition for prevention or treatment of cancer comprising an extract of Oplopanax elatus | |
| CN108477372A (en) | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar anti-aging tranquilizing effect | |
| KR101816193B1 (en) | Composition for inhibiting a cancer metastasis comprising an extract or fraction of herb medicine | |
| KR20200069077A (en) | Composition for preventing, ameliorating or treating atopic dermatitis comprising Apium graveolens hydrolysate as effective component | |
| CN107823610A (en) | Antineoplastic pharmaceutical compositions and preparation method thereof | |
| CN108244323A (en) | A kind of Inonotus obliquus pressed candy of energy anticancer reducing pressure and sugar prevention cerebral thrombus | |
| KR20140064067A (en) | Compositions for preventing and treating diabetes or diabetic complications comprising extracts of zanthoxylum piperitum and piper nigrum | |
| KR101257909B1 (en) | Pharmaceurtical compositions for the prevention or treatment of cancer containing the mixed extract of Phellinus linteus mycelium and cultured Panax Ginseng Cameyer as an active ingredient | |
| CN108324783A (en) | It is white to return ginseng Ling Donggan medicines for cancer | |
| KR102408908B1 (en) | A health functional food comprising composite material extract for preventing or treating obesity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181002 |
|
| RJ01 | Rejection of invention patent application after publication |